跳至主要内容
临床试验/NCT02763306
NCT02763306已完成不适用

Dermal Cryotherapy in Patients Undergoing Abdominoplasty

R2 Dermatology2 个研究点 分布在 1 个国家目标入组 28 人开始时间: 2015年6月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
28
试验地点
2
主要终点
Histologic evaluation of treated skin

研究概览

简要总结

A prospective, interventional, single-arm study to evaluate histologic changes in skin following cryotherapy with the study device.

详细描述

This study is to include healthy adults who intend to undergo an abdominoplasty surgery, and agree to have small areas of their middle and lower abdomen exposed to cooling with the Dermal Cooling System within 180 days before the planned surgery. Exposure of multiple test sites will be completed in areas of skin that will be excised as part of the abdominoplasty procedure. Clinical assessments of the treatment sites at 1-week post-treatment and at 1-month post-treatment intervals throughout the time period prior to surgical excision, and histologic evaluation of the treated skin will be conducted to assess skin changes.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Male or female subjects > 18 years of age.
  • •Subjects eligible, consented, and scheduled for abdominoplasty.
  • •Subject is willing to use photoprotection (e.g., sun avoidance) of the treated areas during the duration of the follow-up period.
  • •Subject has read and signed a written informed consent form. -

排除标准

  • •Subject has medical or surgical treatment in the area of intended treatment in the previous 6 months (e.g., liposuction, mesotherapy, hydroquinone, corticosteroids, laser surgery).
  • •Subject has a known history of subcutaneous injections into the abdomen within the past six months (e.g., insulin, Enbrel).
  • •Subject has a known history of illness or adverse reaction to cold insult (e.g., cryoglobulinemia, cold urticaria, paroxysmal cold hemoglobinuria, Reynaud's disease).
  • •Subject is taking methylxanthines (phosphodiesterase-inhibitors like amino- or theophylline)
  • •Artificial tanning in the area of intended treatment within 1 month (e.g., spray, lotion, tanning bed) or intention to use artificial tanning within the follow-up period.
  • •Subject is unable or unwilling to comply with the study requirements.
  • •Subject has any dermatological conditions or scars (other than stretch marks) within the area of planned abdominoplasty excision that may interfere with the ability to obtain test sites for treatment or evaluation.
  • •Subject has a history of abnormal wound healing or abnormal scarring.
  • •Subject is currently enrolled in a clinical study of any other unapproved investigational drug or device.
  • •Patient is pregnant or intending to become pregnant within the next 6 months.
  • •Patient is lactating or has been lactating in the past 9 months.
  • •Any other condition or laboratory value that would, in the professional opinion of the investigator, potentially affect response or participation in this clinical study, or would pose an unacceptable risk to the patient.

研究组 & 干预措施

Treatment with cryotherapy

Experimental

Treatment with dermal cooling system.

干预措施: Dermal Cooling System (Device)

结局指标

主要结局

Histologic evaluation of treated skin

时间窗: 1-180 days

Identify a range of treatment parameters which elicits a response in melanocytes based upon histologic assessments.

次要结局

  • Access device or procedure-related adverse events(1 - 180 days)

研究者

发起方
R2 Dermatology
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验